Bydureon BCise Approved for Adolescents With Type 2 Diabetes
The expanded approval was based on data from a phase 3 study that evaluated exenatide extended-release in 82 patients aged 10 to 17 years with type 2 diabetes.
Type 2 Diabetes
Delaying Glycemic Control After T2D Diagnosis Raises Risk for All-Cause Mortality, Myocardial Infarction
The researchers examined the relationships of T2D all-cause mortality and myocardial infarction with prior HbA1c values and explored the potential impact of instituting earlier glucose-lowering therapy.
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
For adults newly diagnosed with type 2 diabetes mellitus (T2DM), delays to first-line therapy are longest for older patients, those who are Black or of other ethnicities, and those with multimorbidity.
Pen vs Syringe Insulin Administration for Older Adults With Type 2 Diabetes
Researchers sought to evaluate the role of insulin administration method on glycemic control, hypoglycemia risk, treatment adherence, and quality of life in older adults with type 2 diabetes.
Continuous Glucose Monitoring vs Blood Glucose Meter Monitoring in Type 2 Diabetes
Researchers studied the effectiveness of continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin without prandial insulin in primary care practices.
Medication Type for T2DM May Affect Severe COVID-19 Outcomes
The use of certain classes of diabetes medications prior to severe COVID-19 infection is associated with lower mortality in patients with diabetes.
Dulaglutide Reduces Moderate, Severe Erectile Dysfunction Risk in Men With Type 2 Diabetes
Investigators participating in the REWIND trial sought to evaluate the incidence, prevalence, and progression of erectile dysfunction in a population of men treated with dulaglutide vs placebo.
Type 2 Diabetes Frailty Index Predicts Poor Outcomes: BP and Glucose Interventions Can Mitigate Them
The researchers’ goal was to develop a frailty index and explore the relationship of frailty to subsequent adverse outcomes among participants with type 2 diabetes in the ADVANCE trial.
Updating and Improving Cardiovascular Risk Prediction in Type 2 Diabetes
Investigators hypothesized that cardiovascular risk prediction equations derived before widespread screening would now significantly overestimate risk in screen-detected patients.
Culturally Tailored Shared Medical Appointments Increase Diabetes Knowledge
Intervention significantly increased Black patients confidence in diabetes self-care abilities and perceived knowledge about diabetes.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...